TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. purchase Customization

purchase customization

Leave This Empty:

choose chapter to purchase


Back to Report

table of content

1 Gastrointestinal OTC Drugs Market Overview
1.1 Product Overview and Scope of Gastrointestinal OTC Drugs
1.2 Gastrointestinal OTC Drugs Segment by Type
1.2.1 Global Gastrointestinal OTC Drugs Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Laxatives
1.2.3 Anti-Flatulents
1.2.4 H2-Antaginists
1.2.5 Anti-Diarrheals
1.2.6 PPIs
1.2.7 Anti-Emetics
1.2.8 Other
1.3 Gastrointestinal OTC Drugs Segment by Application
1.3.1 Global Gastrointestinal OTC Drugs Sales Comparison by Application: (2023-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Gastrointestinal OTC Drugs Market Size Estimates and Forecasts
1.4.1 Global Gastrointestinal OTC Drugs Revenue 2017-2030
1.4.2 Global Gastrointestinal OTC Drugs Sales 2017-2030
1.4.3 Gastrointestinal OTC Drugs Market Size by Region: 2017 Versus 2021 Versus 2030
2 Gastrointestinal OTC Drugs Market Competition by Manufacturers
2.1 Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2017-2023)
2.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Manufacturers (2017-2023)
2.3 Global Gastrointestinal OTC Drugs Average Price by Manufacturers (2017-2023)
2.4 Manufacturers Gastrointestinal OTC Drugs Manufacturing Sites, Area Served, Product Type
2.5 Gastrointestinal OTC Drugs Market Competitive Situation and Trends
2.5.1 Gastrointestinal OTC Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Gastrointestinal OTC Drugs Players Market Share by Revenue
2.5.3 Global Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gastrointestinal OTC Drugs Retrospective Market Scenario by Region
3.1 Global Gastrointestinal OTC Drugs Retrospective Market Scenario in Sales by Region: 2017-2023
3.2 Global Gastrointestinal OTC Drugs Retrospective Market Scenario in Revenue by Region: 2017-2023
3.3 North America Gastrointestinal OTC Drugs Market Facts & Figures by Country
3.3.1 North America Gastrointestinal OTC Drugs Sales by Country
3.3.2 North America Gastrointestinal OTC Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Gastrointestinal OTC Drugs Market Facts & Figures by Country
3.4.1 Europe Gastrointestinal OTC Drugs Sales by Country
3.4.2 Europe Gastrointestinal OTC Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Gastrointestinal OTC Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Region
3.5.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Gastrointestinal OTC Drugs Market Facts & Figures by Country
3.6.1 Latin America Gastrointestinal OTC Drugs Sales by Country
3.6.2 Latin America Gastrointestinal OTC Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Gastrointestinal OTC Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Country
3.7.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Gastrointestinal OTC Drugs Historic Market Analysis by Type
4.1 Global Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2023)
4.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2023)
4.3 Global Gastrointestinal OTC Drugs Price by Type (2017-2023)
5 Global Gastrointestinal OTC Drugs Historic Market Analysis by Application
5.1 Global Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2023)
5.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2023)
5.3 Global Gastrointestinal OTC Drugs Price by Application (2017-2023)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2023)
6.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2023)
6.2.4 Pfizer Gastrointestinal OTC Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2023)
6.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Bayer Gastrointestinal OTC Drugs Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Procter & Gamble
6.5.1 Procter & Gamble Corporation Information
6.5.2 Procter & Gamble Description and Business Overview
6.5.3 Procter & Gamble Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2023)
6.5.4 Procter & Gamble Gastrointestinal OTC Drugs Product Portfolio
6.5.5 Procter & Gamble Recent Developments/Updates
6.6 Perrigo
6.6.1 Perrigo Corporation Information
6.6.2 Perrigo Description and Business Overview
6.6.3 Perrigo Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2023)
6.6.4 Perrigo Gastrointestinal OTC Drugs Product Portfolio
6.6.5 Perrigo Recent Developments/Updates
6.7 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Abbott Gastrointestinal OTC Drugs Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Sanofi Gastrointestinal OTC Drugs Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Teva Pharmaceutical
6.9.1 Teva Pharmaceutical Corporation Information
6.9.2 Teva Pharmaceutical Description and Business Overview
6.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2023)
6.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Portfolio
6.9.5 Teva Pharmaceutical Recent Developments/Updates
6.10 Nestle
6.10.1 Nestle Corporation Information
6.10.2 Nestle Description and Business Overview
6.10.3 Nestle Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2023)
6.10.4 Nestle Gastrointestinal OTC Drugs Product Portfolio
6.10.5 Nestle Recent Developments/Updates
6.11 Boehringer Ingelheim
6.11.1 Boehringer Ingelheim Corporation Information
6.11.2 Boehringer Ingelheim Gastrointestinal OTC Drugs Description and Business Overview
6.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2023)
6.11.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Portfolio
6.11.5 Boehringer Ingelheim Recent Developments/Updates
6.12 Reckitt Benckiser
6.12.1 Reckitt Benckiser Corporation Information
6.12.2 Reckitt Benckiser Gastrointestinal OTC Drugs Description and Business Overview
6.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2023)
6.12.4 Reckitt Benckiser Gastrointestinal OTC Drugs Product Portfolio
6.12.5 Reckitt Benckiser Recent Developments/Updates
6.13 Purdue Pharma
6.13.1 Purdue Pharma Corporation Information
6.13.2 Purdue Pharma Gastrointestinal OTC Drugs Description and Business Overview
6.13.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2023)
6.13.4 Purdue Pharma Gastrointestinal OTC Drugs Product Portfolio
6.13.5 Purdue Pharma Recent Developments/Updates
7 Gastrointestinal OTC Drugs Manufacturing Cost Analysis
7.1 Gastrointestinal OTC Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Gastrointestinal OTC Drugs
7.4 Gastrointestinal OTC Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Gastrointestinal OTC Drugs Distributors List
8.3 Gastrointestinal OTC Drugs Customers
9 Gastrointestinal OTC Drugs Market Dynamics
9.1 Gastrointestinal OTC Drugs Industry Trends
9.2 Gastrointestinal OTC Drugs Market Drivers
9.3 Gastrointestinal OTC Drugs Market Challenges
9.4 Gastrointestinal OTC Drugs Market Restraints
10 Global Market Forecast
10.1 Gastrointestinal OTC Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Gastrointestinal OTC Drugs by Type (2023-2030)
10.1.2 Global Forecasted Revenue of Gastrointestinal OTC Drugs by Type (2023-2030)
10.2 Gastrointestinal OTC Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Gastrointestinal OTC Drugs by Application (2023-2030)
10.2.2 Global Forecasted Revenue of Gastrointestinal OTC Drugs by Application (2023-2030)
10.3 Gastrointestinal OTC Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Gastrointestinal OTC Drugs by Region (2023-2030)
10.3.2 Global Forecasted Revenue of Gastrointestinal OTC Drugs by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer